<DOC>
	<DOC>NCT00562094</DOC>
	<brief_summary>The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.</brief_summary>
	<brief_title>Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main inclusion criteria: GERD NERD Main exclusion criteria: Criteria as defined in the Summary of Product Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Pantoprazole</keyword>
	<keyword>eGERD (Erosive Gastroesophageal Reflux Disease)</keyword>
	<keyword>NERD (Non-Erosive Reflux Disease)</keyword>
	<keyword>sleep disorders</keyword>
</DOC>